Isabel Rodríguez Sánchez | Health Sciences | Best Researcher Award | 13387

Assoc Prof Dr. Isabel Rodríguez Sánchez | Health Sciences | Best Researcher Award 

Assoc Prof Dr. Isabel Rodríguez Sánchez, Clínico San Carlos University Hospital, Spain

Assoc. Prof. Dr. Isabel Rodríguez Sánchez is a specialist in Geriatrics at Clínico San Carlos University Hospital in Madrid, Spain. She holds a PhD in Epidemiology and Public Health and serves as an associate professor at the Complutense University of Madrid. Her research focuses on frailty, chronic disease, and functional impairment in older adults, with over 25 scientific publications, many in high-impact journals. Dr. Rodríguez Sánchez also contributes to national health policy as a member of the Spanish Agency for Medicines and Medical Devices.

Profile

Orcid

🎓 Early Academic Pursuits

Assoc. Prof. Dr. Isabel Rodríguez Sánchez began her academic journey with a strong foundation in medicine, graduating from the Universidad Complutense de Madrid in 2014. Her passion for improving the lives of older adults through evidence-based medical practice guided her specialization in Geriatrics, a field she pursued through rigorous training at the Hospital Universitario La Paz, one of Spain’s most reputable institutions for medical education. Her commitment to research and academic excellence was further solidified with the completion of a PhD in Epidemiology and Public Health from the Universidad Autónoma de Madrid in 2021. Her doctoral thesis, “Dolor crónico, deterioro funcional y enfermedad cardiovascular en las personas mayores,” earned the highest distinction: Cum Laude with an Extraordinary Doctorate Award.

🩺 Professional Endeavors

Dr. Rodríguez Sánchez has accumulated a wealth of clinical experience across several prestigious Spanish institutions. She began her medical career as a Médico Interno Residente (MIR) in Geriatrics from 2015 to 2019 at Hospital Universitario La Paz. This formative period laid the groundwork for her deep understanding of aging, frailty, and complex chronic conditions in older adults.

From 2019 to 2020, she worked as a Geriatrics Specialist at the Hospital de Navarra and concurrently served as a Clinical Associate Professor at the University of Navarra, mentoring young medical students in geriatric medicine. Since 2020, she has held the position of Facultativo Especialista de Área (Consultant Geriatrician) at the Hospital Clínico San Carlos in Madrid, one of Spain’s leading academic hospitals.

In addition to her clinical roles, she was appointed as a Member of the Committee for the Safety of Medicines for Human Use at the Spanish Agency of Medicines and Medical Devices (AEMPS) in 2024, demonstrating her engagement with national health governance and patient safety.

🔬 Contributions and Research Focus

Dr. Rodríguez Sánchez’s research has made significant contributions to the field of aging, particularly in the study of frailty, sarcopenia, chronic diseases, and functional impairment. She has authored or co-authored 25 scientific publications, with 13 published in top-tier Q1 journals, and accumulated over 1300 citations.

Her most notable work includes studies on functional decline following COVID-19 hospitalization in the elderly, multimorbidity in older adults, and the integration of technology for assessing pain and sarcopenia. She is also a co-author of seven book chapters, both in Spanish and international publications, further solidifying her expertise in Geriatrics.

Her research is interdisciplinary, often incorporating biomarkers, imaging (e.g., ultrasound for muscle mass), and digital health tools to enhance diagnosis, prevention, and treatment of geriatric syndromes.

🏅 Accolades and Recognition

Dr. Rodríguez Sánchez has earned numerous awards and recognitions that underscore her contributions to geriatric medicine. In 2022, she received the “Best Abstract – ECGI Category (Early-Career Geriatricians Initiative) Stefania Maggi Award” at the European Geriatric Medicine Society Congress in London. Her award-winning study focused on functional impairment in individuals aged 80+ following COVID-19 hospitalization—a prospective study that she both designed and led.

She has also been invited to serve as a peer reviewer for high-impact international journals, such as Aging Research Reviews, Frontiers, Environmental Research, and the Journal of the American Medical Directors Association, reflecting her respected position in the global research community.

🌍 Impact and Influence

Beyond her publications, Dr. Rodríguez Sánchez actively influences healthcare practice and policy through project evaluations for national and international research funding bodies. Her involvement ensures that projects related to frailty, sarcopenia, post-stroke balance evaluation, and chronic pain management using technological solutions are rigorously assessed and guided by clinical relevance and scientific rigor.

Her dual roles in both clinical practice and academic teaching—as a professor at the Complutense University of Madrid since 2022—enable her to shape the next generation of healthcare professionals. She teaches across multiple programs, including Medicine, Nutrition, and the Master’s in Nutrigenetics, promoting an integrated approach to geriatric care.

🌟 Legacy and Future Contributions

Assoc. Prof. Dr. Isabel Rodríguez Sánchez stands out as a dynamic physician-researcher whose work bridges the gap between science, clinical care, and policy. Her dedication to improving health outcomes for older adults, especially the most vulnerable, positions her as a future leader in geriatric innovation.

Looking forward, she is expected to continue advancing multidimensional assessment tools, precision interventions for frailty and sarcopenia, and policy-oriented research that influences national and European standards of care for the elderly.

Her legacy is being built not only on her academic achievements and clinical expertise but also on her role as a mentor, educator, and advocate for dignified and effective aging care. 🌱

Publication Top Notes

ContributorsIsabel Rodriguez; Jose Antonio Carnicero; Alejandro Álvarez-Bustos; Francisco José García-García; Leocadio Rodríguez-Mañas; Helio
Coelho-Junior
Journal: Nutrients
Year: 2025

Research on Frailty: Where We Stand and Where We Need to Go

ContributorsRodríguez-Mañas, L.; Rodriguez-Sánchez, I.
Journal: American Medical Directors Association
Year: 2021
ContributorsBani Hassan, E.; Phu, S.; Vogrin, S.; Escobedo Terrones, G.; Pérez, X.; Rodriguez-Sanchez, I.; Duque, G.
Journal: Calcified Tissue International
Year: 2019

 

 

Mojtaba Aghaei | Medicine and Health Sciences | Best Researcher Award

Mojtaba Aghaei | Medicine and Health Sciences | Best Researcher Award

Dr Mojtaba Aghaei, Thalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Iran

Mojtaba Aghaei is a Master of Science and Research Assistant at the Thalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Iran. 🌟 Specializing in Hematology, Blood Banking, Cancer Therapy, and Cell Signaling, Mojtaba’s research focuses on genetic variants, diabetes mellitus, and chronic lymphoblastic leukemia. 🧬 His projects include systematic reviews and meta-analyses on topics such as advanced glycation end products in PCOS, and the impact of sulfur dioxide on semen quality. With 50 citations and ongoing research on ischemia-modified albumin, his work advances understanding in hematology and endocrinology. 📊🔬

Publication profile

Google scholar

Academic and Professional 

Mojtaba Aghaei is a Research Assistant at the Thalassemia & Hemoglobinopathy Research Center, specializing in Hematology, Blood Banking, and Cancer Therapy. His expertise extends to Cancer Cell Signaling, Flow Cytometry, Cell Culture, Endocrinology, and Gynecology.

Research Projects

Recent studies have explored various aspects of health and disease through systematic reviews and meta-analyses. 🧬 Key areas include the impact of genetic variants on antifungal immunity in hematologic malignancies, associations between Galectin-3 and gestational diabetes, and the role of advanced glycation end products in polycystic ovary syndrome (PCOS). 🔬 Research also investigates the effects of environmental pollutants on semen quality and the influence of biomarkers like Pro-BNP on cardiac health. 📊 Additionally, studies address the correlation between eosinophils and IgE in asthma, and factors influencing acute chest syndrome and thrombotic purpura in sickle cell disease. 🌍💉

Research focus

Based on the provided publications, the research focus of SS Bahreiny appears to be on reproductive health, particularly in the context of polycystic ovary syndrome (PCOS) and male fertility. The systematic reviews and meta-analyses span various aspects, such as oxidative stress, hormonal imbalances, and genetic factors related to PCOS, as well as environmental influences on semen quality. This research aims to understand and improve the diagnosis and treatment of reproductive disorders through comprehensive analyses of circulating biomarkers and environmental impacts. 🧬🔬🩺

Publication top notes

Association of free radical product and polycystic ovary syndrome: A systematic review and meta-analysis

Circulating nesfatin-1 levels in women with polycystic ovary syndrome: A systematic review and meta-analysis

Circulating Galectin-3 levels in women with polycystic ovary syndrome: A meta-analysis

The influence of CDKAL1 (rs7754840) gene polymorphism on susceptibility to gestational diabetes mellitus in pregnant women: A systematic review and meta-analysis

Association between ambient particulate matter and semen quality parameters: a systematic review and meta-analysis

Exploring the relationship between ambient sulfur dioxide and semen quality parameters: A systematic review and meta-analysis

Circulating levels of advanced glycation end products in females with polycystic ovary syndrome: a meta-analysis

Genetic Variants of Dectin-1 and their antifungal immunity impact in Hematologic Malignancies: A Comprehensive Systematic Review

A closer look at Galectin-3: its association with gestational diabetes mellitus revealed by systematic review and meta-analysis

 

Ferdinando D’Amico | Medicine and Health Sciences | Best Researcher Award

Ferdinando D’Amico | Medicine and Health Sciences | Best Researcher Award

Dr Ferdinando D’Amico, IRCCS San Raffaele Hospital, Italy

Dr. Ferdinando D’Amico is a distinguished gastroenterologist at IRCCS San Raffaele Hospital in Milan, Italy, with expertise in gastroenterology and endoscopy. 🎓 He completed his residency in Gastroenterology/Digestive Diseases and earned his PhD at Hunimed University, focusing on histology in inflammatory bowel diseases. His academic journey includes a degree in Medicine and Surgery from “Cattolica del Sacro Cuore” University, where he researched intestinal permeability and atherosclerosis. 🏥 His training included internships in gastroenterology and cardiology at “Agostino Gemelli” Hospital in Rome. Dr. D’Amico is proficient in English and French, and skilled in digital communication. 🌍🔬

Publication profile

Scopus

Education 

🎓 From 2003 to 2008, attended Classical High School, graduating with highest honours. From 2009 to 2015, pursued a Degree in Medicine and Surgery at “Cattolica del Sacro Cuore” University, Rome, also graduating with highest honours. 🏆 The dissertation, titled “Alterations in Intestinal Permeability and Inflammation: A Novel Potential Mechanism of Atherosclerosis,” was supervised by Professor Filippo Crea. 📜 Currently registered with the Ordine Provinciale dei Medici Chirurghi e degli Odontoiatri di Caserta, registration number 7593. 🩺

Experience

From November 1, 2016, to November 2, 2020, [Name] completed their residency in Gastroenterology/Digestive System Diseases at Hunimed University in Pieve Emanuele, Italy, graduating with highest honors. They then pursued a Ph.D. at the same institution, focusing on “The Role of Histology in Inflammatory Bowel Diseases,” under the guidance of Prof. Silvio Danese. From January 1, 2021, to February 9, 2024, they worked as a Gastroenterologist at the IRCCS San Raffaele Hospital in Milan, Italy, in the Gastroenterology and Endoscopy Unit, also directed by Prof. Silvio Danese. 🏥📚🩺

Research focus

Based on the provided publications, the research focus appears to be on inflammatory bowel diseases (IBD), specifically Crohn’s disease and ulcerative colitis. The studies address various aspects such as comparing treatments (e.g., tofacitinib vs. ustekinumab), assessing remission through non-invasive methods, and evaluating regulatory guidance for JAK inhibitors. The research also explores the use of biologics and other therapies in managing IBD, including switching between different treatment forms. This indicates a strong emphasis on optimizing treatment strategies and improving patient outcomes in IBD. 🌟📚💊

Publication top notes

Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study

Ultrasound remission after biologic induction and long-term endoscopic remission in Crohn’s disease: a prospective cohort study

Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study

The role of filgotinib in ulcerative colitis and Crohn’s disease

A new national survey of centers for cognitive disorders and dementias in Italy

An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study

Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn’s disease

MMX mesalamine in ulcerative colitis: Major advantages towards classical mesalamine formulations

Advancing transmural remission as a treatment target in Crohn’s disease: The future of tight-control strategy?

Noninvasive Assessment of Postoperative Disease Recurrence in Crohn’s Disease: A Multicenter, Prospective Cohort Study on Behalf of the Italian Group for Inflammatory Bowel Disease

 

 

Matheus Sewastjanow-Silva | Health Sciences | Best Researcher Award

Dr. Matheus Sewastjanow-Silva | Health Sciences | Best Researcher Award

Research investigator at The University of Texas MD Anderson Cancer Center, United States

Matheus Sewastjanow da Silva is a Research Investigator at the University of Texas MD Anderson Cancer Center, focusing on clinical studies databases and manuscript analysis. Previously, he worked in Jaffer Ajani’s lab and was a General Practitioner in Brazil, providing emergency and outpatient care. He holds an M.D. from the Federal University of Minas Gerais (UFMG), with internships in various medical specialties at institutions like A.C. Camargo Cancer Center and Jackson Memorial Hospital. Matheus has extensive research experience in surgery and immunology and has actively participated in volunteer medical campaigns and student leadership roles.

Professional Profiles:

🎓 Education

Matheus Sewastjanow da Silva, M.D., earned his Doctor of Medicine (M.D.) from the Federal University of Minas Gerais School of Medicine in Brazil (2012-2018). His education included additional internships at prominent institutions. He completed a rural outpatient care internship in Esmeraldas, Brazil, and specialized training in Otolaryngology – Head & Neck Surgery at A.C. Camargo Cancer Center, São Paulo, and in Skin, Head & Neck, and Micro/Reconstructive Surgery at Barretos Cancer Hospital. Dr. da Silva also trained in Transplant Surgery and Mohs Micrographic Surgery at the University of Miami. His education was supplemented by various courses, including Pediatric Advanced Life Support (PALS), Advanced Cardiovascular Life Support (ACLS), clinical emergencies, and advanced dermatological surgery. Additionally, he completed courses in clinical therapeutics, psychosomatic diseases, primary immunodeficiencies, and languages (French and Latin). This diverse and rigorous training underscores his commitment to comprehensive medical education and patient care.

Professional Experience

Dr. Matheus Sewastjanow da Silva is currently a Research Investigator in Shirley Su’s research group at the Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center (07/2024-present). His responsibilities include managing clinical studies/trials databases, analyzing and writing manuscripts, and utilizing tools such as RedCap, Epic/SlicerDicer, Foundry, Universe, and Prometheus. Previously, he worked as a Research Investigator in Jaffer Ajani’s lab at the Department of Gastrointestinal Medical Oncology at the same institution (09/2020-06/2024), where he handled clinical samples, patient enrollment, and various laboratory techniques. Before his roles at MD Anderson, Dr. da Silva served as a Physician/General Practitioner in multiple clinics and hospitals across Brazil, providing both outpatient and emergency care, including treating COVID-19 patients. His roles included positions at Nazare Public Family Medicine Clinic, Private Hospital Santa Helena, Public Hospital Vinte e Cinco de Maio, and several Public Emergency Care Centers. Additionally, he gained research experience as an Assistant at the Federal University of Minas Gerais, contributing to studies in General Surgery and Biochemistry, Cellular, and Molecular Immunology.

Research Interest

Dr. Matheus Sewastjanow da Silva is deeply interested in clinical and translational research, focusing on head and neck surgery, gastrointestinal oncology, and emergency medicine. His current research in Shirley Su’s group at MD Anderson Cancer Center involves filling and maintaining clinical studies and trials databases, as well as analyzing and writing manuscripts. He has extensive experience with advanced tools like RedCap, Epic/SlicerDicer, Foundry, Universe, and Prometheus. Dr. da Silva’s previous research in Jaffer Ajani’s lab involved the collection and processing of clinical samples, patient enrollment, DNA/RNA extraction, cell culture, and various molecular biology techniques such as qPCR, Western Blotting, and viral transfections. His research interests extend to the development of novel therapeutic strategies, biomarker discovery, and improving patient outcomes in oncology. Additionally, he is passionate about medical education and the integration of research findings into clinical practice to enhance healthcare delivery.

Award and Honors

Dr. Matheus Sewastjanow da Silva has been recognized for his outstanding contributions to medicine and research through numerous awards and honors. His notable achievements include multiple grant awards and scholarships from esteemed organizations such as the National Council for Scientific and Technological Development (CNPq) and the Research Support Foundation of the State of Minas Gerais (FAPEMIG). Throughout his academic and professional journey, Dr. da Silva has demonstrated exceptional commitment and excellence in his field, earning accolades for his research work, particularly in biochemistry, cellular and molecular immunology, and oncology. His dedication to advancing medical knowledge and improving patient care has been consistently acknowledged, solidifying his reputation as a distinguished physician and researcher in the medical community.

Research Experience 🔬

  • Research Assistant at UFMG General Surgery Laboratory – Andy Petroianu M.D., PhD (07/2015 – 12/2017)
    Roles: Research design, patient consenting, data collection/analysis, database management, manuscript preparation.
  • Research Assistant at UFMG Biochemistry, Cellular and Molecular Immunology Laboratory II – Dawidson Assis Gomes, Msc, PhD (10/2012 – 07/2015)
    Grant Awards: CNPq, FAPEMIG
    Roles: Lab preparations, rodent handling, tissue processing, DNA/RNA extraction, immunohistochemistry, PCR, ELISA, Western Blotting, flow cytometry, data analysis, manuscript preparation.

Research Skills

Proficient in managing clinical studies and trials databases using RedCap, Epic/SlicerDicer, Foundry, Universe, and Prometheus, I have extensive experience in collecting, processing, and managing clinical samples, including blood, ascites, and tissue. My molecular techniques expertise encompasses DNA/RNA extraction, qPCR, Western Blotting, viral transfections, and immunohistochemistry. Additionally, I am skilled in cell isolation, culture, and viral transfections. I have significant experience in rodent handling and conducting mouse studies. Competent in statistical analysis and data interpretation using various software tools, I am also proficient in writing and reviewing abstracts, articles, manuscripts, posters, and slide presentations. My laboratory skills include preparing buffers, tissue staining, cryostat tissue sectioning, PCR, ELISA, flow cytometry, and cell culture.

Publications

  • SMARCA4 Mutations in Gastroesophageal Adenocarcinoma: An Observational Study via a Next-Generation Sequencing Panel
    • Authors: Yamashita, K., Sewastjanow-Silva, M., Yoshimura, K., …, Wang, L., Ajani, J.A.
    • Year: 2024
  • Chemotherapy Plus Atezolizumab Pre- and Post-Resection in Localized Esophageal or Gastroesophageal Junction Adenocarcinomas: A Phase I/II Single-Arm Study
    • Authors: Sewastjanow-Silva, M., Xiao, L., Gonzalez, G.N., …, Ajani, J.A., Murphy, M.B.
    • Year: 2024
  • Human Epidermal Growth Factor Receptor-2 Gastric Adenocarcinoma: Expanding Therapy of a Recognized Target
    • Authors: Rogers, J.E., Yamashita, K., Sewastjanow-Silva, M., …, Waters, R.E., Ajani, J.
    • Year: 2023
    • Citations: 2
  • Challenges and Prospects of Patient-Derived Xenografts for Cancer Research
    • Authors: Jin, J., Yoshimura, K., Sewastjanow-Silva, M., Song, S., Ajani, J.A.
    • Year: 2023
    • Citations: 12
  • Evolution of Immune and Stromal Cell States and Ecotypes during Gastric Adenocarcinoma Progression
    • Authors: Wang, R., Song, S., Qin, J., …, Ajani, J.A., Wang, L.
    • Year: 2023
    • Citations: 14
  • Epithelial SOX9 Drives Progression and Metastases of Gastric Adenocarcinoma by Promoting Immunosuppressive Tumour Microenvironment
    • Authors: Fan, Y., Li, Y., Yao, X., …, Ajani, J.A., Song, S.
    • Year: 2023
    • Citations: 24
  • A New Intronic Quantitative PCR Method Led to the Discovery of Transformation from Human Ascites to Murine Malignancy in a Mouse Model
    • Authors: Jin, J., Huo, L., Fan, Y., …, Song, S., Ajani, J.A.
    • Year: 2023
    • Citations: 1
  • Nivolumab Combination Therapy as First-Line Treatments for Unresectable, Advanced or Metastatic Esophageal Squamous Cell Carcinoma
    • Authors: Rogers, J.E., Yamashita, K., Sewastjanow-Silva, M., …, Waters, R., Ajani, J.A.
    • Year: 2023
    • Citations: 1
  • GRK3 Is a Poor Prognosticator and Serves as a Therapeutic Target in Advanced Gastric Adenocarcinoma
    • Authors: Li, Y., Fan, Y., Xu, J., …, Song, S., Ajani, J.A.
    • Year: 2022
    • Citations: 3
  • Current Immune Checkpoint Inhibitor Genetic Biomarker Exploration in Gastrointestinal Tumors
    • Authors: Rogers, J.E., Yamashita, K., Sewastjanow Silva, M., Ajani, J.A.
    • Year: 2022